ARL 17477, a Potent and Selective Neuronal NOS Inhibitor Decreases Infarct Volume after Transient Middle Cerebral Artery Occlusion in Rats
Open Access
- 1 July 1996
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 16 (4), 599-604
- https://doi.org/10.1097/00004647-199607000-00009
Abstract
We tested the effects of administration of a selective neuronal nitric oxide synthase (nNOS) inhibitor, ARL 17477, on ischemic cell damage and regional cerebral blood flow (rCBF), in rats subjected to transient (2 h) middle cerebral artery (MCA) occlusion and 166 h of reperfusion (n = 48) and in rats without MCA occlusion (n = 25), respectively. Animals were administered ARL 17477 (i.v.): 10 mg/kg; 3 mg/kg; 1 mg/kg; N-nitro-L-arginine (L-NA) 10 mg/kg L-NA 1 mg/kg; and Vehicle. Administration of ARL 17477 1 mg/kg, 3 mg/kg and 10 mg/kg reduced ischemic infarct volume by 53 (p < 0.05), 23, and 6.5%, respectively. L-NA 1 mg/kg and 10 mg/kg increased infarct volume by 2 and 15%, respectively (p > 0.05). Administration of ARL 17477 (10 mg/kg) significantly (p < 0.05) decreased rCBF by 27 ± 5.3 and 24 ± 14.08% and cortical NOS activity by 86 ± 14.9 and 91 ± 8.9% at 10 min or 3 h, respectively, and did not alter mean arterial blood pressure (MABP). L-NA (10 mg/kg) significantly reduced rCBF by 23 ± 9.8% and NOS activity by 81 ± 7% and significantly (p < 0.05) increased MABP. Treatment with 3 mg/kg and 1 mg/kg ARL 17477 reduced rCBF by only 2.4 ± 4.5 and 0%, respectively, even when NOS activity was reduced by 63 ± 13.4 and 45 ± 15.7% at 3 h, respectively, (p < 0.05). The data demonstrate that ARL 17477 inhibits nNOS in the rat brain and causes a dose-dependent reduction in infarct volume after transient MCA occlusion.Keywords
This publication has 27 references indexed in Scilit:
- Tetrahydrobiopterin and Dysfunction of Endothelial Nitric Oxide Synthase in Coronary ArteriesCirculation, 1995
- Effects of Cerebral Ischemia in Mice Deficient in Neuronal Nitric Oxide SynthaseScience, 1994
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994
- The Complex Role of Nitric Oxide in the Pathophysiology of Focal Cerebral IschemiaBrain Pathology, 1994
- Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by ImmunohistochemistryBiological Chemistry Hoppe-Seyler, 1994
- Nitric oxide production during focal cerebral ischemia in rats.Stroke, 1993
- Nitric oxide: foe or friend to the injured brain?Proceedings of the National Academy of Sciences, 1993
- Chapter 6 Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemiaPublished by Elsevier ,1993
- The Effect of Hypothermia on Transient Middle Cerebral Artery Occlusion in the RatJournal of Cerebral Blood Flow & Metabolism, 1992
- Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.Proceedings of the National Academy of Sciences, 1989